Table 3C

Considerations when participants are unsure about taking the test

Will not take the test (n=186; 22.4%)
More information about specific diseases tested.60 (32%)126 (68%)
More information about the technology used for the screening programme.99 (53%)87 (47%)
More information about postscreening pathways including adoption and surrogacy options and IVF subsidies.105 (56%)81 (44%)
  • Number indicates the responses while parentheses indicates percentages.